Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer

Published:2011-07-14 Issue:7 Volume:104 Page:755-759
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Su Chung-Kuang,Yeh Kun-Tu,Yeh Chao-Bin,Wang Po-Hui,Ho Esther Shih-Chu,Chou Ming-Chih,Liu Kai-Cheng,Yang Shun-Fa,Yi Yu-Chiao

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.22035/fullpdf

Reference32 articles.

1. The urokinase plasminogen activator system: Role in malignancy;Duffy;Curr Pharm Des,2004

2. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy;Sidenius;Cancer Metastasis Rev,2003

3. uPAR: A versatile signalling orchestrator;Blasi;Nat Rev,2002

4. Urokinase plasminogen activator system: A multifunctional role in tumor progression and metastasis;Choong;Clin Orthop Relat Res,2003

5. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis;Pepper;Arterioscler Thromb Vasc Biol,2001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of single nucleotide polymorphisms (4G/5G) of plasminogen activator inhibitor-1 and the risk factors for placenta-related obstetric complications;Blood Coagulation & Fibrinolysis;2023-07-17

2. Role of adipocytokines in endometrial cancer progression;Frontiers in Pharmacology;2022-12-12

3. Exploring a possible association between the occurrence of the SERPINE1-675 4G/5G (rs1799889) polymorphism and the increased risk of esophageal cancer in the Caucasian population;Biochemistry and Biophysics Reports;2021-12

4. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer;Technology in Cancer Research & Treatment;2021-01-01

5. Endometrial cancer: a genetic point of view;Translational Cancer Research;2020-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3